Lucid Diagnostics Inc

LUCDNASDAQ · Surgical & Medical Instruments & Apparatus

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

190.8M

on 2026-06-30, from 46.7M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$175.0M

S-3 of 2025-12-05. 1 prospectus supplement filed under it since. S-3 ↗

$25.0M

Maxim Group, agreement of 2026-03-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

4.3 quarters

$47.3M on 2025-09-30 ÷ $10.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-04-23	Public offering	18,000,000	$1.00	$18.0M	424B5 ↗
2025-04-09	Public offering	12,500,000	$1.20	$15.0M	424B5 ↗
2025-03-04	Public offering	not read	$1.10	$15.3M	424B5 ↗

Also on file: $21.9M convertible notes, 2024-11-22 8-K ↗